期刊： ANNALS OF PHARMACOTHERAPY, 2021; 55 (9)
Objective To review the pharmacological characteristics, clinical evidence, and place in therapy of satralizumab for the treatment of neuromyelitis op......
期刊： ANNALS OF PHARMACOTHERAPY, 2021; 55 (8)
Background: Researchers had contradictory conclusions about the role of probiotics in preventing ventilator-associated pneumonia (VAP), which has led ......
期刊： ANNALS OF PHARMACOTHERAPY, 2021; 55 (10)
Objective: To review the pharmacological characteristics, clinical evidence, and place in the management of acute postoperative pain severe enough to ......
期刊： ANNALS OF PHARMACOTHERAPY, 2021; 55 (9)
Objective: To review medical management of inoperable malignant bowel obstruction. Data Sources: A literature review using PubMed and MEDLINE database......
期刊： ANNALS OF PHARMACOTHERAPY, 2020; 54 (7)
Background: Cyclophosphamide is one of the most important chemotherapeutic drugs. Known as a widely accepted treatment strategy, chemotherapy may dama......
期刊： ANNALS OF PHARMACOTHERAPY, 2020; 54 (8)
Background: A total of 15% to 40% of adult inflammatory bowel disease (IBD) patients are obese. The influence of obesity on anti-tumor necrosis factor......
期刊： ANNALS OF PHARMACOTHERAPY, 2020; 54 (8)
Background: Aflibercept has been widely used in treating diabetic macular edema (DME). However, the effect of aflibercept in treating DME refractory t......
期刊： ANNALS OF PHARMACOTHERAPY, 2020; 54 (10)
Background: The best way to administer steroids for sudden sensorineural hearing loss (SSHL) is still unclear. The present study was aimed at estimati......
期刊： ANNALS OF PHARMACOTHERAPY, 0; ()
Background: Various pharmacokinetic (PK) equations and software have been developed to individualize vancomycin dosing. However, the benefit of using ......
期刊： ANNALS OF PHARMACOTHERAPY, 2019; 53 (10)
Background: Adverse drug outcomes in the elderly have led to the development of lists of potentially inappropriate medications (PIMs), such as the Bee......
期刊： ANNALS OF PHARMACOTHERAPY, 0; ()
Background: The addition of bevacizumab to neoadjuvant chemotherapy improves the pathological complete response rate of human epidermal growth factor ......
期刊： ANNALS OF PHARMACOTHERAPY, 0; ()
Background: Tacrolimus (TAC) is widely used after liver transplantation, but the therapeutic window is narrow. Objective: The purpose was to study bot......
期刊： ANNALS OF PHARMACOTHERAPY, 2020; 54 (3)
Background: Midline catheters (MCs) have arisen as alternatives to peripherally inserted central catheters (PICCs) for both general intravenous therap......
